BRAF and colorectal carcinoma: The purpose of this study was to develop and validate a prognostic model for BRAF V600E-mutated CRC patients based on the clinical and pathological information of BRAF V600E-mutated CRC patients in order to distinguish subgroups with different prognoses at an early stage and adopt targeted treatment strategies.